Kelly Culwell is Chief Medical Officer of Evofem Biosciences, Inc.. Currently has a direct ownership of 273,390 shares of EVFM, which is worth approximately $2,733. The most recent transaction as insider was on May 20, 2021, when has been sold 42,061 shares (Common Stock) at a price of $0.86 per share, resulting in proceeds of $36,172. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 273K
0% 3M change
0% 12M change
Total Value Held $2,733

Kelly Culwell Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2021
SELL
Payment of exercise price or tax liability
$36,172 $0.86 p/Share
42,061 Reduced 13.33%
273,390 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
200,000 Added 38.8%
315,451 Common Stock
KC

Kelly Culwell

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on EVFM

Follow Evofem Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVFM shares.

Notify only if

Insider Trading

Get notified when an Evofem Biosciences, Inc. insider buys or sells EVFM shares.

Notify only if

News

Receive news related to Evofem Biosciences, Inc.

Track Activities on EVFM